Buprenorphine Hydrochloride Tablet
Product Images NDC 0121-1019

4 FDA label images from Pai Holdings, Llc Dba Pai Pharma · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 0121-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buptabs 1)

Chemical Structure (Buptabs 1)
Chemical structure of buprenorphine hydrochloride, depicting its molecular bonds and arrangement, including characteristic features such as a cyclopropyl group and hydroxyl groups.*
FDA Label Image

Figure (Buptabs 2)

Figure (Buptabs 2)
An instructional diagram showing a person placing a sublingual tablet under the tongue, demonstrating proper administration of buprenorphine hydrochloride sublingual tablets.*
FDA Label Image

Principal Display Panel (2 mg Sublingual Tablet 30-count Bottle Label)

Principal Display Panel (2 mg Sublingual Tablet 30-count Bottle Label)
Label for Buprenorphine Sublingual Tablets 2 mg by PAI Holdings, LLC dba PAI Pharma, containing 30 tablets. The label includes dosage instructions, storage temperature range (20 to 25°C), and emphasizes dispensing the Medication Guide to each patient. NDC 0121-1019-30 with barcode and regulatory information is displayed.*
FDA Label Image

Principal Display Panel (8 mg Sublingual Tablet 30-count Bottle Label)

Principal Display Panel (8 mg Sublingual Tablet 30-count Bottle Label)
Label for Buprenorphine Sublingual Tablets 8 mg by PAI Pharma, containing 30 tablets. The label includes storage instructions, dispensing guidance, a barcode, and indicates the product is prescription-only with DEA Schedule III classification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.